Polydisulfide Based Biodegradable Macromolecular Magnetic Resonance Imaging Contrast Agents

Area of Science:

• Biomedical imaging
• Materials science
• Radiochemistry

Background:

• Macromolecular contrast agents for MRI offer advantages like prolonged circulation and tumor targeting.
• However, their slow excretion poses safety concerns, hindering clinical approval.
• Small molecular agents are cleared rapidly but lack the targeting benefits of macromolecular agents.

Purpose of the Study:

• To review the development and properties of polydisulfide Gd(III) complexes as biodegradable macromolecular MRI contrast agents.
• To highlight their potential for safe and effective cardiovascular and cancer imaging.
• To address the limitations of existing MRI contrast agents.

Main Methods:

• Design and synthesis of polydisulfide Gd(III) complexes.
• In vivo evaluation of contrast enhancement in vasculature and tumor tissues.
• Assessment of biodegradability and in vivo clearance mechanisms.
• Comparison with small molecular contrast agents regarding efficacy and safety.

Main Results:

• Polydisulfide Gd(III) complexes demonstrate superior contrast enhancement in blood vessels and tumors.
• These agents degrade in vivo into small chelates, enabling rapid renal excretion.
• Animal models show minimal long-term tissue accumulation, comparable to small molecular agents.
• Effective contrast enhancement was observed in both vasculature and tumor tissues.

Conclusions:

• Polydisulfide Gd(III) complexes represent a promising class of biodegradable macromolecular MRI contrast agents.
• Their dual behavior of initial macromolecular properties followed by rapid small molecule clearance enhances safety.
• These agents hold significant potential for clinical translation in cardiovascular and oncology imaging.